Martin And Harris Laboratories Limited

Pharmaceutical manufacturing and fund management company with multiple locations.

1993 | Active
Last Updated: May 15, 2024

Martin And Harris Laboratories Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.00 Cr
  • Company Age 31 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 10.50 Cr
  • Satisfied Charges ₹ 8.37 Cr
  • Revenue Growth 20.49%
  • Profit Growth 3.16%
  • Ebitda 2.27%
  • Net Worth 12.90%
  • Total Assets 13.90%

About Martin And Harris Laboratories

Martin And Harris Laboratories Limited (MAHLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 22 July 1993 and has a history of 31 years and seven months. Its registered office is in Na, Haryana.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.00 Cr.

The company currently has active open charges totaling ₹10.50 Cr. The company has closed loans amounting to ₹8.37 Cr, as per Ministry of Corporate Affairs (MCA) records.

Vivek Padgaonkar, Ashok Sen, Nasim Uddin, and Two other members serve as directors at the Company.

Company Details

  • Location Na, Haryana
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    martinandharris.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239HR1993PLC033630

  • Company No.

    033630

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    22 Jul 1993

  • Date of AGM

    29 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

Who are the key members and board of directors at Martin And Harris Laboratories?

Board Members (5)

NameDesignationAppointment DateStatus
Vivek Padgaonkar Country flag representing In Director 28-Nov-2022Current
Ashok Sen Country flag representing In Director 30-Mar-2023Current
Nasim Uddin Country flag representing In Director 18-Jun-2022Current
Harnam Singh Country flag representing In Director 26-Nov-2016Current
Shanker Laxman Country flag representing In Director 11-Nov-2011Current

Financial Performance of Martin And Harris Laboratories.

Martin And Harris Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.49% increase. The company also saw a slight improvement in profitability, with a 3.16% increase in profit. The company's net worth Soared by an impressive increase of 12.9%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
20.49%
Revenue from Operations
19.33%
Total Assets
13.90%
Profit or Loss
3.16%
Net Worth
12.90%
EBITDA
2.27%

What is the Ownership and Shareholding Structure of Martin And Harris Laboratories?

In 2023, Martin And Harris Laboratories had a public holding of 99.99%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹10.50 Cr

Satisfied Charges

₹8.37 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 10.50 Cr

Latest Charge Details

DateLenderAmountStatus
18 May 2023Hdfc Bank Limited₹10.50 CrOpen
24 Sep 1996Dena Bank₹1.71 CrSatisfied
22 Aug 1996Dena Bank₹1.71 CrSatisfied
21 Aug 1996Others₹4.95 CrSatisfied

How Many Employees Work at Martin And Harris Laboratories?

Martin And Harris Laboratories has a workforce of 71 employees as of May 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Martin And Harris Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Martin And Harris Laboratories's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Martin And Harris Laboratories

Recent activity within the organization

  • Annual General Meeting

    Martin And Harris Laboratories Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.

    29 Sep 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 10.50 Cr with Charge ID 100724186 was registered on 18 May 2023.

    18 May 2023

  • Charges

    A charge registered on 21 Aug 1996 via Charge ID 90056593 with Others was fully satisfied on 16 May 2023.

    16 May 2023

  • Balance Sheet

    Martin And Harris Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

    31 Mar 2023

  • Director Appointment

    Ashok Chandra Sen was appointed as a Director was appointed as a Director on 30 Mar 2023 & has been associated with this company since 1 year 10 months .

    30 Mar 2023

  • Director Appointment

    Vivek Manohar Padgaonkar was appointed as a Director was appointed as a Director on 28 Nov 2022 & has been associated with this company since 2 years 2 months .

    28 Nov 2022

Frequently asked questions

  • Martin And Harris Laboratories Limited was incorporated on 22 Jul 1993.

  • The authorized share capital of Martin And Harris Laboratories Limited is ₹ 5.00 Cr and paid-up capital is ₹ 4.00 Cr.

  • Currently 5 directors are associated with Martin And Harris Laboratories Limited.

    • Vivek Manohar Padgaonkar
    • Ashok Chandra Sen
    • Nasim Uddin
    • Harnam Thakur Singh
    • Shanker Laad Laxman
  • As per Ministry of Corporate Affairs (Mca), the registered address of Martin And Harris Laboratories Limited is Nh-8 Delhi Jaipur Highway Village Pachgaon (Fazalwas) Distt.Gurgaon, Harya. Harya India, Na, Haryana.

  • The corporate identification number (CIN) of Martin And Harris Laboratories Limited is U24239HR1993PLC033630 and the company number is 033630 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Martin And Harris Laboratories Limited is https://www.martinandharris.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Martin And Harris Laboratories Limited has risen by 20.49%.

  • As Per 2023 financial reports, 71 employees are currently employed by Martin And Harris Laboratories Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Martin And Harris Laboratories Limited has experienced an upsurge of 12.90%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Martin And Harris Laboratories Limited amount to ₹ 10.50 Cr.

  • The most recent Balance Sheet for Martin And Harris Laboratories Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Drug Formulation & Development